PHOSPHORYLASE INHIBITING AGENT

PURPOSE:To obtain the titled inhibiting agent containing at least one kind of compound selected from a pyridine derivative and pyrimidine derivative. CONSTITUTION:At least one kind of compound selected from a compound (e.g. 3-chloro-2,6-dihydroxypyridine) expressed by formula I [R is H or halogen; R...

Full description

Saved in:
Bibliographic Details
Main Authors SHIRASAKA TETSUHIKO, FUKUSHIMA MASAKAZU, FUJII SETSUO, TATSUMI KUNIHIKO
Format Patent
LanguageEnglish
Published 18.10.1988
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:PURPOSE:To obtain the titled inhibiting agent containing at least one kind of compound selected from a pyridine derivative and pyrimidine derivative. CONSTITUTION:At least one kind of compound selected from a compound (e.g. 3-chloro-2,6-dihydroxypyridine) expressed by formula I [R is H or halogen; R is H, amino or halogen; R is H, cyano or halogen) and compound [e.g. 6-amino-5-chloro-2,4-(1H,3H)-pyrimidinedione] expressed by formula II (R is halogen; R is amino which may be substituted by tenoyl; R is H, tenoyl or hydroxy lower alkoxy lower alkyl) is incorporated to provide the aimed pyrimidine nucleotide phosphorylase inhibiting agent. The agent inhibits strongly decomposition by pyrimidine nucleotide phosphorylase of antiulcer agent and simultaneously side effect such as weight decrease is very few and safeness is high also when the agent is used together with the antiulcer agent.
Bibliography:Application Number: JP19870085033